Ildong Pharmaceutical Co., Ltd. (249420.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.16T
Enterprise Value1.24T
P/E Ratio23.11
PEG Ratio-0.55
Price/Sales Ratio0.68
Price/Book Ratio1.56
Enterprise/Revenue0.83
Enterprise/EBITDA-13.89

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue566.93B
Revenue/Share18,580.08
Gross Profit214.76B
EBITDA39.9B
Net Income27.66B
Diluted EPS936.77

Balance Sheet

Total Cash60.37B
Total Cash/Share1,908.04
Total Debt142.05B
Total Debt/Equity0.55
Current Ratio1
Book Value Per Share7,887.68

Price History

52-Week Change-55.9
52-Week High45,050
52-Week Low11,250
Moving Average 50 Days13,840.8
Moving Average 200 Days21,714.3

Statistics

Average Volume304,215
Shares Outstanding31.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate200
Trailing Annual Dividend Yield1.58
Payout Ratio0.37
Last Split Factor21:20
Last Split DateMarch 05, 2020
AD